SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-23-001028
Filing Date
2023-09-28
Accepted
2023-09-28 19:13:36
Documents
3
Period of Report
2023-09-26

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 5494
2 poa.htm EX-24 11091
3 image00001.jpg GRAPHIC 687
  Complete submission text file 0000905148-23-001028.txt   18952
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BUTTERFLY NETWORK, INC. 530 OLD WHITFIELD STREET GUILFORD CT 06437
Business Address
Miller Mary (Reporting) CIK: 0001841088 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41551 | Film No.: 231291366